Reuters logo
in 7 months
BRIEF-Adocia and Lilly announce successful completion insulin pump study biochaperone Lispro
December 16, 2016 / 5:10 PM / in 7 months

BRIEF-Adocia and Lilly announce successful completion insulin pump study biochaperone Lispro

1 Min Read

Dec 16 (Reuters) - Adocia SA :

* Adocia and Lilly announce successful completion of an insulin pump study with biochaperone Lispro in people with type 1 diabetes

* Biochaperone Lispro U100 demonstrated a statistically significant increase in insulin exposure over first 30 minutes after a mealtime bolus compared to humalog

* Biochaperone Lispro U100 and humalog showed similar safety results and were well tolerated

* An accelerated absorption profile of biochaperone lispro U100 was observed across three insulin delivery devices tested Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below